Todd Berner

450 total citations
15 papers, 342 citations indexed

About

Todd Berner is a scholar working on Urology, Rheumatology and Epidemiology. According to data from OpenAlex, Todd Berner has authored 15 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Urology, 6 papers in Rheumatology and 5 papers in Epidemiology. Recurrent topics in Todd Berner's work include Urinary Bladder and Prostate Research (7 papers), Pelvic floor disorders treatments (6 papers) and Urinary Tract Infections Management (5 papers). Todd Berner is often cited by papers focused on Urinary Bladder and Prostate Research (7 papers), Pelvic floor disorders treatments (6 papers) and Urinary Tract Infections Management (5 papers). Todd Berner collaborates with scholars based in United States, Canada and United Kingdom. Todd Berner's co-authors include Adrian Wagg, Billy Franks, Bárbara Ramos, David Castro‐Díaz, Victor W. Νitti, Emad Siddiqui, Con Kelleher, Carrie D. Allen, Joseph G. Ouslander and Eric G. Tangalos and has published in prestigious journals such as Journal of the American Geriatrics Society, Headache The Journal of Head and Face Pain and Molecular Genetics and Metabolism.

In The Last Decade

Todd Berner

15 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd Berner United States	9	197	167	130	42	39	15	342
Gloria M. Harrison Canada	10	320 1.6×	300 1.8×	154 1.2×	24 0.6×	51 1.3×	12	412
P. Gatcomb United States	11	90 0.5×	88 0.5×	39 0.3×	133 3.2×	112 2.9×	11	516
Alison Deighton United States	8	50 0.3×	40 0.2×	38 0.3×	80 1.9×	24 0.6×	17	264
A.‐C. Kinn Sweden	10	138 0.7×	101 0.6×	32 0.2×	23 0.5×	76 1.9×	25	335
An‐Sofie Goessaert Belgium	12	237 1.2×	127 0.8×	68 0.5×	44 1.0×	114 2.9×	37	447
Julie K. Taraday United States	6	82 0.4×	77 0.5×	91 0.7×	20 0.5×	190 4.9×	7	473
Hisaka Minami Japan	11	50 0.3×	16 0.1×	60 0.5×	63 1.5×	52 1.3×	32	309
Toshikazu Otani Japan	10	149 0.8×	65 0.4×	25 0.2×	62 1.5×	109 2.8×	33	294
Karl Erik Andersson United States	9	188 1.0×	116 0.7×	28 0.2×	278 6.6×	77 2.0×	12	517
Sheila O. Brown United States	4	243 1.2×	169 1.0×	77 0.6×	81 1.9×	24 0.6×	6	291

Countries citing papers authored by Todd Berner

Since Specialization

Citations

This map shows the geographic impact of Todd Berner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Berner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Berner more than expected).

Fields of papers citing papers by Todd Berner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Berner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Berner. The network helps show where Todd Berner may publish in the future.

Co-authorship network of co-authors of Todd Berner

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Berner. A scholar is included among the top collaborators of Todd Berner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Berner. Todd Berner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Meckley, Lisa M., et al.. (2020). Patient experience with subcutaneous immunoglobulin 20%, Ig20Gly, for primary immunodeficiency diseases: a prespecified post hoc analysis of combined data from 2 pivotal trials. BMC Immunology. 21(1). 24–24. 2 indexed citations

Himmelreich, Nastassja, Riccardo Montioli, Mariarita Bertoldi, et al.. (2019). Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook. Molecular Genetics and Metabolism. 127(1). 12–22. 61 indexed citations

Wagg, Adrian, Victor W. Νitti, Con Kelleher, et al.. (2016). Oral pharmacotherapy for overactive bladder in older patients: mirabegron as a potential alternative to antimuscarinics. Current Medical Research and Opinion. 32(4). 621–638. 46 indexed citations

Suehs, Brandon T., et al.. (2016). Effect of Potentially Inappropriate Use of Antimuscarinic Medications on Healthcare Use and Cost in Individuals with Overactive Bladder. Journal of the American Geriatrics Society. 64(4). 779–787. 20 indexed citations

Wagg, Adrian, et al.. (2016). Treatment Patterns for Patients on Overactive Bladder Therapy: A Retrospective Statistical Analysis Using Canadian Claims Data. Journal of health economics and outcomes research. 3(1). 43–55. 8 indexed citations

Ng, Daniel, et al.. (2016). Evaluating Outcomes in Patients with Overactive Bladder within an Integrated Healthcare Delivery System Using a Treatment Patterns Analyzer.. PubMed. 9(6). 343–353. 6 indexed citations

Barkin, Jack, et al.. (2015). Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.. PubMed. 22(4). 7914–23. 7 indexed citations

Zarowitz, Barbara J., et al.. (2015). Clinical Burden and Nonpharmacologic Management of Nursing Facility Residents with Overactive Bladder and/or Urinary Incontinence. The Consultant Pharmacist. 30(9). 533–542. 28 indexed citations

Wagg, Adrian, Billy Franks, Bárbara Ramos, & Todd Berner. (2015). Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada. Canadian Urological Association Journal. 9(9-10). 343–343. 91 indexed citations

10.

Zarowitz, Barbara J., et al.. (2015). Challenges in the Pharmacological Management of Nursing Home Residents with Overactive Bladder or Urinary Incontinence. Journal of the American Geriatrics Society. 63(11). 2298–2307. 13 indexed citations

11.

Ernst, Frank R., et al.. (2015). Opioid Medication Practices Observed in Chronic Pain Patients Presenting for All-Causes to Emergency Departments: Prevalence and Impact on Health Care Outcomes. Journal of Managed Care & Specialty Pharmacy. 21(10). 925–936. 9 indexed citations

12.

Ivanova, Jasmina, Eleanor Hayes‐Larson, Rachael Sorg, Howard G. Birnbaum, & Todd Berner. (2014). Healthcare resource use and costs of privately insured patients who switch, discontinue, or persist on anti-muscarinic therapy for overactive bladder. Journal of Medical Economics. 17(10). 741–750. 17 indexed citations

13.

Kirson, Noam Y., Alan G. White, Howard G. Birnbaum, et al.. (2011). Direct and indirect costs of patients treated with extended-release oxymorphone HCl or controlled-release oxycodone HCl. Journal of Medical Economics. 15(1). 87–95. 2 indexed citations

14.

Berner, Todd, et al.. (2011). A Comparison of Daily Average Consumption Of Oxycodone Controlled Release (OxyContin CR) And Oxymorphone Extended Release (Opana ER) In Patients With Low Back Pain.. PubMed. 36(3). 139–44. 6 indexed citations

15.

Silberstein, Stephen D., Todd Berner, John R. Tobin, Qinfang Xiang, & John C. Campbell. (2009). Scheduled Short‐Term Prevention With Frovatriptan for Migraine Occurring Exclusively in Association With Menstruation. Headache The Journal of Head and Face Pain. 49(9). 1283–1297. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact